Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper-Reference-Cited by-同舟云学术

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

Published:2020-09-26 Issue:2 Volume:49 Page:215-231
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Los-Arcos Ibai,Iacoboni Gloria,Aguilar-Guisado Manuela,Alsina-Manrique Laia,Díaz de Heredia Cristina,Fortuny-Guasch Claudia,García-Cadenas Irene,García-Vidal Carolina,González-Vicent Marta,Hernani Rafael,Kwon Mi,Machado Marina,Martínez-Gómez Xavier,Maldonado Valentín Ortiz,Pla Carolina Pinto,Piñana José Luis,Pomar Virginia,Reguera-Ortega Juan Luis,Salavert Miguel,Soler-Palacín Pere,Vázquez-López Lourdes,Barba Pere^ORCID,Ruiz-Camps Isabel

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s15010-020-01521-5.pdf

Reference101 articles.

1. Bondanza A, Bonini C, Fehse B, Hudecek M. Cellular therapy with engineered T cells, efficacy and side effects. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT handbook. 7th ed. Berlin: Springer; 2019. p. 449–455.

2. Forman SJ, Kalos M, June CH. Adoptive T‐cell therapy for malignancy in the setting of hematopoietic cell transplantation. In: Antin JH, Appelbaum FR, Forman SJ, Negrin RS, editors. Thomas’ hematopoietic cell transplantion. 5th ed. Wiley-Blackwell; 2016. p. 826–35.

3. Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, et al. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2019;16:45–63.

4. Budde LE, Zaia JA. CD19 CAR-T therapy and sepsis: dancing with the devil. Blood. 2018;131:7–8.

5. Wang Z, Han W. Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy. Biomark Res. 2018;6:4.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

2. Regulation of CAR transgene expression to design semiautonomous CAR-T;Molecular Therapy: Oncology;2024-09

3. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

4. Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies;ImmunoTargets and Therapy;2024-08

5. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies;Molecular Therapy;2024-08